Multimodal particles, methods and uses thereof

• US 10,105,456 B2
• Filed: 12/19/2013
• Issued: 10/23/2018
• Est. Priority Date: 12/19/2012
• Status: Active Grant

• Current Assignee: Sloan-Kettering Institute For Cancer Research (Memorial Sloan-Kettering Cancer Center)
• Original Assignee: Sloan-Kettering Institute For Cancer Research (Memorial Sloan-Kettering Cancer Center)
• Inventors: Harmsen, Stefan, Wall, Matthew, Kircher, Moritz
• Primary Examiner(s): Cabral, Robert S
• Application Number:
  US14/653,177
• Publication Number:
  US 20150328346A1
• Time in Patent Office: 1,769 Days
• CPC Class Codes: A61K 49/0093 Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
• CPC Class Codes: A61K 49/1824 coated or functionalised nanoparticles liposomes A61K49/1812; nanoemulsions A61K49/1806; micelles A61K49/1809
• CPC Class Codes: A61K 51/1244 microparticles or nanoparticles, e.g. polymeric nanoparticles

Abstract

The present disclosure, among other things, provides a composition of a particle including a substrate; at least a first condensation layer comprising at least a first dopant entity; and at least a second layer comprising a second dopant entity. In some embodiments, different dopant entities are included in different layers. In some embodiments, such dopant entities are or comprise detectable entities. This, in some embodiments, provided technologies achieve multi-modality particles. Among the many advantages of provided technologies include the ability to image particles by a plurality of distinct imaging modalities and/or in a plurality of contexts (e.g., pre-surgical, intraoperative and/or post-surgical environments). The present invention provides methods that include a single administration of particles to a subject, followed by a plurality of steps that comprise imaging the administered particles, which steps may utilize different imaging technologies and/or be performed at different times and/or in different environments.

Claims

1. A composition comprising at least one particle comprised of:

a nanoscale metal or metal alloy substrate;

a first condensation layer that extends a distance from the nanoscale metal or metal alloy substrate, wherein the distance is up to 10 nm, and wherein the first condensation layer comprises a first dopant entity that is or comprises a SE(R)RS-active agent; and

a second condensation layer comprising a second dopant entity, wherein the second dopant entity is a detectable entity selected from the group consisting of fluorochromes, MM agents, photoacoustic-active dyes, upconverting materials, positron emission tomography (PET) tracers, single photon emission tomography (SPECT) tracers, computed tomography (CT) agents, X-ray agents, ultrasound (US) agents, and combinations thereof so that the first dopant entity and the second dopant entity are detectable by different imaging modalities.

2. The composition of claim 1, wherein the second condensation layer has a thickness within the range of about 0.5 nm to about 5 μ

m and/or wherein the first dopant entity is positioned within 5 nm, or 10 nm of the surface of the nanoscale metal or metal alloy substrate.

3. The composition of claim 1, wherein the first condensation layer and/or the second condensation layer comprise(s) a material selected from the group consisting of metal, semi-metal, non-metal, oxides, borides, carbides, sulfides and nitrides of the metal, semi-metal or non-metal, oligomers, polypeptides, polymers and combinations thereof.

4. The composition of claim 3, wherein the metal, semi-metal or non-metal is or comprises silica, titania, zirconia, germania, alumina, tantalum pentoxide, or any combinations thereof.

5. The composition of claim 1, wherein the first condensation layer and the second condensation layer are comprised of a same material and/or wherein the first condensation layer and/or the second condensation layer comprise(s) silica layers.

6. The composition of claim 3, wherein the first condensation layer and/or the second condensation layer comprise(s) oligomers, polypeptides, polymers, or any combination thereof.

7. The composition of claim 1, wherein the second dopant entity is a NIR fluorescent agent.

8. The composition of claim 7, further comprising a third dopant entity.

9. The composition of claim 1, further comprising a buffer layer positioned between the first condensation layer and the second condensation layer, wherein the buffer layer lacks a dopant entity.

10. The composition of claim 1, wherein each of the first dopant entity and the second dopant entity is directly associated within each of the first condensation layer and the second condensation layer.

11. The composition of claim 1, wherein each of the first dopant entity and the second dopant entity is indirectly associated within each of the first condensation layer and the second condensation layer via a linker, or a chelator.

12. The composition of claim 1, wherein the nanoscale metal or metal alloy substrate is spherical.

13. The composition claim 1, wherein the nanoscale metal or metal alloy substrate is non-spherical.

14. The composition of claim 1, wherein the nanoscale metal or metal alloy substrate is or comprises a material selected from the group consisting of metals, metal oxides, liposomes, upconverting materials, semiconductors, and combinations thereof.

15. The composition of claim 14, wherein the metal is selected from the group consisting of gold, silver, copper, or any other material capable of sustaining localized surface plasmon resonance, and combinations thereof.

16. The composition of claim 1, wherein the nanoscale metal or metal alloy substrate is associated with surface primers and/or with capping agent entities.

17. The composition of claim 1, wherein the at least one particle is substantially free of surface primers.

18. The composition of claim 1, wherein the at least one particle has a diameter of about 5 nm to about 1000 nm or about 5 nm to about 200 nm.

19. A method of preparing a particle, comprising:

combining a first precursor solution of a first condensation layer in water and alcohol with a first dopant entity;

combining the first precursor solution with a nanoscale metal or metal alloy substrate under conditions and for a time necessary and sufficient to apply onto the nanoscale metal or metal alloy substrate the first condensation layer, which first condensation layer extends a distance from the nanoscale metal or metal alloy substrate which is up to 10 nm, resulting in a particle;

combining a second precursor solution of a second condensation layer in water and alcohol with a second dopant entity;

combining the second precursor solution with the particle under conditions and for a time necessary and sufficient to apply onto the particle the second condensation layer, which second condensation layer has a second predetermined thickness;

wherein the first dopant entity is or comprises a SE(R)RS-active agent, and

wherein the second dopant entity is a detectable entity selected from the group consisting of fluorochromes, MRI agents, photoacoustic-active dyes, upconverting materials, positron emission tomography (PET) tracers, single photon emission tomography (SPECT) tracers, computed tomography (CT) agents, X-ray agents, ultrasound (US) agents, and combinations thereof so that the first dopant entity and the second dopant entity are detectable by different imaging modalities.

20. The method of claim 19, wherein the nanoscale metal or metal alloy substrate further comprises at least one layer.

21. A method comprising a step of providing to a site of interest a collection of particles each comprised of:

a nanoscale metal or metal alloy substrate;

a first condensation layer that extends a distance from the nanoscale metal or metal alloy substrate, wherein the distance is up to 10 nm, and wherein the first condensation layer comprises a first dopant entity that is or comprises a SE(R)RS-active agent; and

a second condensation layer comprising a second dopant entity,

wherein the second dopant entity is a detectable entity selected from the group consisting of fluorochromes, MRI agents, photoacoustic-active dyes, upconverting materials, positron emission tomography (PET) tracers, single photon emission tomography (SPECT) tracers, computed tomography (CT) agents, X-ray agents, ultrasound (US) agents, and combinations thereof so that the first dopant entity and the second dopant entity are detectable by different imaging modalities.

22. The method of claim 21, wherein the site of interest is or comprises a solid tumor and wherein the step of providing comprises administering the collection of particles to a location and in an amount such that particles from the collection of the particles localize to the solid tumor.

23. The method of claim 21, wherein the particles further comprise a targeting entity;

and/or

wherein the nanoscale metal or metal alloy substrate is gold; and

/or

wherein the second dopant entity comprises an entity selected from the group consisting of radionuclides, fluorescent dyes, and combinations thereof.

24. The method of claim 21, wherein the second dopant entity is a NIR fluorescent agent.

25. The method of claim 21, further comprising a step or a plurality of steps of imaging administered particles.

26. The method of claim 25, wherein different imaging modalities are utilized in different imaging steps and wherein different imaging steps utilizing different imaging modalities are performed substantially simultaneously.

27. The method of claim 25, wherein each imaging step of the plurality of imaging steps comprises utilizing an imaging modality selected from the group consisting of MRI, PET, SPECT, CT, X-ray, ultrasound, photoacoustic detection, fluorescent/Raman spectroscopy, and combinations thereof.

28. The method of claim 21, wherein the second dopant entity comprises an entity selected from the group consisting of radionuclides, fluorescent dyes, and combinations thereof, the method further comprising a first step of imaging administered particles, wherein the radionuclide generates Cerenkov signal.

29. The method of claim 28, further comprising a second step of imaging administered particles, wherein the radionuclide causes secondary Cerenkov induced fluorescence.